DeoxyATP Producing hiPSC Derived Cardiomyocyte to Restore Cardiac Function in Heart Failure

Scientists engineered ribonucleotide reductase overexpressing human-induced pluripotent stem cell-derived cardiomyocytes as a novel cell therapy strategy to improve contractility and regeneration in myocardial infarction.